Affordable Access

Publisher Website

Exploring the effect of PARP-1 flexibility in docking studies

Authors
Journal
Journal of Molecular Graphics and Modelling
1093-3263
Publisher
Elsevier
Volume
45
Identifiers
DOI: 10.1016/j.jmgm.2013.08.006
Keywords
  • Replica Exchange Molecular Dynamics
  • Parp
  • Molecular Docking
  • Virtual Screening
Disciplines
  • Biology
  • Medicine

Abstract

Abstract Poly(ADP-ribose)polymerase-1 (PARP-1) is an enzyme belonging to the ADP-ribosyltransferase family. A large body of works has validated PARP-1 as an attractive drug target for different therapeutic areas, including cancers and ischemia. Accordingly, sampling the conformational space of the enzyme is pivotal to understand its functions and improve structure-based drug discovery approaches. In the first part of this study we apply replica exchange molecular dynamic (REMD) simulations to sample the conformational space of the catalytic domain of PARP-1 in the ligand-bound and unbound forms. In the second part, we assess how and to what extend the emerging enzyme flexibility affects the performance of docking experiments of a library of PARP-1 inhibitors. This study pinpoints a putative key role of conformational shifts of Leu324, Tyr325 and Lys242 in opening an additional binding site pocket that affects the binding of ligands to the catalytic cleft of PARP-1. Furthermore, it highlights the improvement of the enrichment factor of active ligands obtained in docking experiments when using conformations generated with REMD simulations of ligand-bound PARP-1.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

A review on PARP1 inhibitors: Pharmacophore modeli...

on Current Topics in Medicinal Ch... 2014

PARP inhibition: PARP1 and beyond.

on Nat Rev Cancer April 2010

Exploring the binding features of rimonabant analo...

on Journal of molecular modeling December 2008
More articles like this..